{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:04:31Z","timestamp":1790129071734,"version":"4.0.1"},"reference-count":51,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Cu(II) and Zn(II) morpholinyldithiocarbamato complexes, formulated as [Cu(MphDTC)2] and [Zn(\u03bc-MphDTC)2(MphDTC)2], where MphDTC is morpholinyldithiocarbamate were synthesized and characterized by elemental analysis, spectroscopic techniques and single-crystal X-ray crystallography. The molecular structure of the Cu(II) complex revealed a mononuclear compound in which the Cu(II) ion was bonded to two morpholinyl dithiocarbamate ligands to form a four-coordinate distorted square planar geometry. The molecular structure of the Zn(II) complex was revealed to be dinuclear, and each metal ion was bonded to two morpholinyl dithiocarbamate bidentate anions, one acting as chelating ligand, the other as a bridge between the two Zn(II) ions. The anticancer activity of the morpholinyldithiocarbamate ligand, Cu(II) and Zn(II) complexes were evaluated against renal (TK10), melanoma (UACC62) and breast (MCF7) cancer cells by a Sulforhodamine B (SRB) assay. Morpholinyldithiocarbamate was more active than the standard drug parthenolide against renal and breast cancer cell lines, and [Zn(\u03bc-MphDTC)2(MphDTC)2] was the most active complex against breast cancer. The copper(II) complex had a comparable activity with the standard against renal and breast cancer cell lines but showed an enhanced potency against melanoma when compared to parthenolide.<\/jats:p>","DOI":"10.3390\/molecules25163584","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T07:25:03Z","timestamp":1597044303000},"page":"3584","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Synthesis, Crystal Structures and Anticancer Studies of Morpholinyldithiocarbamato Cu(II) and Zn(II) Complexes"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8581-2387","authenticated-orcid":false,"given":"Peter A.","family":"Ajibade","sequence":"first","affiliation":[{"name":"School of Chemistry and Physics, University of KwaZulu-Natal, Private Bag X01, Scottsville, Pietermaritzburg 3209, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fartisincha P.","family":"Andrew","sequence":"additional","affiliation":[{"name":"School of Chemistry and Physics, University of KwaZulu-Natal, Private Bag X01, Scottsville, Pietermaritzburg 3209, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandipha L.","family":"Botha","sequence":"additional","affiliation":[{"name":"School of Chemistry and Physics, University of KwaZulu-Natal, Private Bag X01, Scottsville, Pietermaritzburg 3209, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nolwazi","family":"Solomane","sequence":"additional","affiliation":[{"name":"School of Chemistry and Physics, University of KwaZulu-Natal, Private Bag X01, Scottsville, Pietermaritzburg 3209, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,8,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_2","first-page":"239","article-title":"Mechanisms of chemotherapeutic drug resistance in cancer therapy\u2014A quick review","volume":"48","author":"Liu","year":"2009","journal-title":"J. Obstet. Gynecol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: An overview","volume":"6","author":"Housman","year":"2014","journal-title":"Cancers"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1634\/theoncologist.1-3-180","article-title":"Anticancer drug development","volume":"1","author":"Connors","year":"1996","journal-title":"Oncologist"},{"key":"ref_5","first-page":"38","article-title":"Transition metal complexes as potential therapeutic agents","volume":"5","author":"Shazia","year":"2010","journal-title":"Biotechnol. Mol. Biol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1080\/00958970802072765","article-title":"Synthesis, characterization and in vitro antiprotozoal studies of iron(III) complexes of some antimalarial drugs","volume":"61","author":"Ajibade","year":"2008","journal-title":"J. Coord. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.ccr.2009.02.019","article-title":"On the medicinal chemistry of gold complexes as anticancer drugs","volume":"253","author":"Ingo","year":"2009","journal-title":"Coord. Chem. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1515\/revic-2015-0008","article-title":"Development of ruthenium-based complexes as anticancer agents: Toward a rational design of alternative receptor targets","volume":"36","author":"Adeniyi","year":"2016","journal-title":"Rev. Inorg. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0006-2952(97)81490-6","article-title":"Oxaliplatin, Tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute\u2019s Anticancer Drug Screen Panel","volume":"52","author":"Olivier","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1517\/13543780903362437","article-title":"Satraplatin: Leading the new generation of oral platinum agents","volume":"18","author":"Bhargava","year":"2009","journal-title":"Expert Opin. Investig Drugs"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Oliveira, J.W.F., Rocha, H.A.O., Queiroz de Medeiros, W.M.T., and Silva, M.S. (2019). Application of Dithiocarbamates as Potential New Antitrypanosomatids-Drugs: Approach Chemistry, Functional and Biological. Molecules, 24.","DOI":"10.3390\/molecules24152806"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2174\/138955712802762040","article-title":"Dithiocarbamate-Based Coordination Compounds as Potent Proteasome Inhibitors in Human Cancer Cells","volume":"12","author":"Buac","year":"2012","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1139\/cjpp-2017-0693","article-title":"Biological effect and molecular docking of anticancer palladium and platinum complexes with morpholine dithiocarbamate on human serum albumin as a blood carrier protein","volume":"96","author":"Hosseini","year":"2018","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.molstruc.2017.10.106","article-title":"Metal complexes of alkyl-aryl dithiocarbamates: Structural studies, anticancer potentials and applications as precursors for semiconductor nanocrystals","volume":"1155","author":"Andrew","year":"2018","journal-title":"J. Mol. Struct."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jscs.2017.08.007","article-title":"Synthesis, spectral characterization, theoretical, antimicrobial, DNA interaction and in vitro anticancer studies of Cu(II) and Zn(II) complexes with pyrimidine-morpholine based Schiff base ligand","volume":"22","author":"Sankarganesh","year":"2018","journal-title":"J. Saudi Chem. Soc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ica.2016.06.036","article-title":"Review article: Anticancer activity, DNA-binding and DNA-denaturing aptitude of palladium(II) dithiocarbamates","volume":"451","author":"Amir","year":"2016","journal-title":"Inorg. Chim. Acta"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ica.2017.04.040","article-title":"Synthesis, characterization, in vitro cytotoxicity and DNA interaction study of phosphanegold(I) complexes with dithiocarbamate ligands","volume":"464","author":"Altaf","year":"2017","journal-title":"Inorg. Chiim. Acta"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/00958972.2016.1255328","article-title":"Two new heteroleptic ruthenium(II) dithiocarbamates: Synthesis, characterization, DFT calculation and DNA binding","volume":"70","author":"Hayat","year":"2017","journal-title":"J. Coord. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"490","DOI":"10.18632\/oncotarget.13448","article-title":"New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status","volume":"8","author":"Altaf","year":"2017","journal-title":"Oncotarget"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/acs.jmedchem.8b01031","article-title":"New water-soluble copper(II) complexes with morpholine\u2013thiosemicarbazone hybrids: Insights into the anticancer and antibacterial mode of action","volume":"62","author":"Ohui","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.saa.2013.07.101","article-title":"Synthesis and spectral characterization of Schiff base complexes of Cu(II), Co(II), Zn(II) and VO(IV) containing 4-(4-aminophenyl) morpholine derivatives: Antimicrobial evaluation and anticancer studies","volume":"117","author":"Dhahagani","year":"2014","journal-title":"Spectrochim. Acta Part A"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"075","DOI":"10.7324\/JAPS.2014.401014","article-title":"Synthesis, characterization, and anticancer studies of some morpholine derived Schiff bases and their metal complexes","volume":"4","author":"Gwaram","year":"2014","journal-title":"J. Appl. Pharm. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1080\/07391102.2018.1527724","article-title":"Antiproliferative activity of morpholine-based compounds on MCF-7 breast cancer, colon carcinoma C26, and normal fibroblast NIH-3T3 cell lines and study of their binding affinity to calf thymus-DNA and bovine serum albumin","volume":"37","author":"Rahimi","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_24","first-page":"1777","article-title":"Emphasizing morpholine and its derivatives (MAID): A typical candidate of pharmaceutical importance","volume":"14","author":"Rupak","year":"2016","journal-title":"Int. J. Chem. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.saa.2016.07.054","article-title":"Design, synthesis and DNA-binding study of some novel morpholine linked thiazolidinone derivatives","volume":"173","author":"War","year":"2017","journal-title":"Spectrochim. Acta Part A"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1021\/jm100112j","article-title":"A medicinal chemist\u2019s guide to molecular interactions","volume":"53","author":"Bissantz","year":"2010","journal-title":"J. Med. Chem"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/cmdc.200700059","article-title":"Predicting and tuning physicochemical properties in lead optimization: Amine basicities","volume":"2","author":"Morgenthaler","year":"2007","journal-title":"Chem. Med. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1021\/jm201699w","article-title":"Non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase: Synthesis, structure\u2013activity relationships, and pharmacokinetics","volume":"55","author":"Ndungu","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s11094-020-02098-x","article-title":"9,10-Anthraquinone dithiocarbamates as potential pharmaceutical substances with pleiotropic actions: Computerized prediction of biological activity and experimental validation","volume":"53","author":"Stasevich","year":"2020","journal-title":"Pharm. Chem. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e01687","DOI":"10.1016\/j.heliyon.2019.e01687","article-title":"Syntheses, physicochemical characterization, antibacterial studies on potassium morpholine dithiocarbamate nickel(II), copper(II) metal complexes and their ligands","volume":"5","author":"Balakrishnan","year":"2019","journal-title":"Heliyon"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"119431","DOI":"10.1016\/j.ica.2020.119431","article-title":"Synthesis, characterization and anti-cancer studies of Mn(II), Cu(II), Zn(II) and Pt(II) dithiocarbamate complexes\u2014Crystal structures of the Cu(II) and Pt(II) complexes","volume":"504","author":"Ajibade","year":"2020","journal-title":"Inorg. Chim. Acta"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"032042","DOI":"10.1088\/1742-6596\/1341\/3\/032042","article-title":"In vitro antibacterial and anticancer activity of Zn (II) Valinedithiocarbamate complexes","volume":"1341","author":"Kartina","year":"2019","journal-title":"J. Phys. Conf. Ser."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1080\/00958972.2018.1489537","article-title":"Synthesis, characterization and anticancer studies of bis-(N-methyl-1-phenyldithiocarbamato) Cu(II), Zn(II), and Pt(II) complexes: Single crystal X-ray structure of the copper complex","volume":"71","author":"Andrew","year":"2018","journal-title":"J. Coord. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1080\/17415993.2014.912280","article-title":"Synthesis, structural and optical properties of ZnS, CdS and HgS nanoparticles from dithiocarbamato single molecule precursors","volume":"35","author":"Mbese","year":"2014","journal-title":"J. Sulfur Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1021\/ic048260v","article-title":"Gold dithiocarbamate derivatives as potential antineoplastic agents: Design, spectroscopic properties, and in vitro antitumor activity","volume":"44","author":"Ronconi","year":"2005","journal-title":"Inorg. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1080\/17415993.2019.1703986","article-title":"Synthesis and crystal structures of Pb(II) dithiocarbamates complexes: Precursors for PbS nanophotocatalyst","volume":"41","author":"Oluwalana","year":"2020","journal-title":"J. Sulfur Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e4363","DOI":"10.1002\/aoc.4363","article-title":"Synthesis and characterization of copper(II) dithiocarbamate complexes involving pyrrole and ferrocenyl moieties and their utility for sensing anions and preparation of copper sulfide and copper\u2013iron sulfide nanoparticles","volume":"32","author":"Gurumoorthy","year":"2018","journal-title":"Appl. Organomet. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.jorganchem.2008.05.017","article-title":"Syntheses and characterization of ferrocenylthiocarboxylate-containing coordination compounds for nonlinear optics","volume":"693","author":"Yang","year":"2008","journal-title":"J. Organomet. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4172\/pharmaceutical-sciences.1000381","article-title":"Synthesis, Spectroscopic Characterization and Biological Evaluation of Ni(II), Cu(II) and Zn(II) complexes of diphenyldithiocarbamate","volume":"80","author":"Khan","year":"2018","journal-title":"Indian J. Pharm. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ica.2013.06.008","article-title":"The crystal structure of [Cu (S2CNC4H8O)2]: An interesting structural motif constructed by intermolecular S \u2026 S and C\u2013H \u2026 Cu interactions","volume":"408","author":"Hogarth","year":"2013","journal-title":"Inorg. Chim. Acta"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jscs.2017.09.002","article-title":"Functionalized zinc(II) dithiocarbamate complexes: Synthesis, spectral and molecular structures of bis (N-cyclopropyl-N-4-methoxybenzyldithiocarbamato-S, S\u2032) zinc(II) and (2, 2\u2032-bipyridine) bis (N-cyclopropyl-N-4-methoxybenzyldithiocarbamato-S, S\u2032) zinc(II)","volume":"22","author":"Sathiyaraj","year":"2018","journal-title":"J. Saudi Chem. Soc."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1107\/S0108270188003865","article-title":"Structures of bis (piperidine-1-dithiocarbamato) nickel (II) and bis (piperidine-1-dithiocarbamato) copper (II)","volume":"44","author":"Radha","year":"1988","journal-title":"Acta Crystallogr. Sect. C Cryst. Struct. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/cjoc.20010190909","article-title":"Crystal structure and spectroscopic studies of Bis (morpholine dithiocarbamate) Nickel (II) complex, Ni (C4H8ONCS2)2","volume":"19","author":"Pan","year":"2001","journal-title":"Chin. J. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.molstruc.2018.05.068","article-title":"Synthesis, characterization and anticancer studies of bis (1-phenylpiperazine dithiocarbamato) Cu(II), Zn(II) and Pt(II) complexes: Crystal structures of 1-phenylpiperazine dithiocarbamato-S, S\u2032 zinc(II) and Pt(II)","volume":"1170","author":"Andrew","year":"2018","journal-title":"J. Mol. Struct."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"m1067","DOI":"10.1107\/S160053680302419X","article-title":"The first dinuclear zinc (II) dithiocarbamate complex with butyl substituent groups","volume":"59","author":"Neves","year":"2003","journal-title":"Acta Crystallogr. Sect. E Struct. Rep. Online"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.poly.2014.10.002","article-title":"Syntheses, crystal structures and photoluminescent properties of new homoleptic and heteroleptic zinc (II) dithiocarbamato complexes","volume":"85","author":"Bharti","year":"2015","journal-title":"Polyhedron"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/00958970802255741","article-title":"Synthesis and crystal structure of a dinuclear zinc(II)-dithiocarbamate complex, bis{[(\u03bc2-pyrrolidinedithiocarbamato-S, S\u2032) (pyrrolidinedithiocarbamato-S, S\u2032) zinc(II)]}","volume":"62","author":"Shahid","year":"2009","journal-title":"J. Coord. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1080\/00958972.2020.1768248","article-title":"Synthesis and crystal structure of bis (thiomorpholinyldithiocarbamato) Zn (II): Structural, optical, and photocatalytic studies of ZnS nanoparticles from the complex","volume":"73","author":"Ajibade","year":"2020","journal-title":"J. Coord. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1107\/S0021889808042726","article-title":"OLEX2: A complete structure solution, refinement and analysis program","volume":"42","author":"Dolomanov","year":"2009","journal-title":"J. Appl. Crystallogr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S0108767307043930","article-title":"A short history of SHELX","volume":"64","author":"Sheldrick","year":"2008","journal-title":"Acta Crystallogr. Sect A Found. Crystallogr."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. C"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/16\/3584\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:57:22Z","timestamp":1760176642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/16\/3584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":51,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2020,8]]}},"alternative-id":["molecules25163584"],"URL":"https:\/\/doi.org\/10.3390\/molecules25163584","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,6]]}}}